Abstract:Objective: To investigate the relationship between NDRG1 and metastasis of breast cancer and the effects of NDRG1 overexpression on the proliferation and invasion of breast cancer cells. Methods: NDRG1 was detected at its protein level by immunohistochemistry (IHC) and its messenger RNA (mRNA) was detected by real-time reverse transcriptase-polymerase chain reaction (real time RT-PCR) in clinical breast cancer specimens. Liposome was used to transiently transfer NDRG1 into MDA-MB-231, a highly invasive human breast cancer cell line. The proliferation of MDA-MB-231 was measured by Bromodeoxy Uridine (BrdU) incorporation assay and the transfection effect on cell cycle distribution was determined by fluorescence assisted cell sorting (FACS). The invasive ability of the transfected cells was investigated by reconstituted matrigel invasion and polycarbonate filters migration experiments. Results: NDRG1 expressions at protein and mRNA levels in tumors of patients with lymph node metastases were significantly lower as compared with those with localized breast cancers (P < 0.01). The amount of NDRG1 mRNA in MCF7, a relatively non-invasive breast cancer cell line, was 10.8 times higher than that in MDA-MB-231 cells (P < 0.01). The BrdU incorporation rate declined significantly (P < 0.05) in NDRG1 overexpressing MDA-MB-231 cells. An increase of the cell population at G 0/G1 phase was observed 48 hours post-transfection along with a decrease of cell population at S phase. Overexpression of NDRG1 significantly retarded the invasiveness of MDA-MB-231 cells in matrigel-coated invasion chambers (P < 0.05), when compared to cells transfected with control vectors. However, the migration abilities of cells with or without the transfection were virtually identical. Conclusions: NDRG1 expression reversely correlates with breast cancer metastasis and progression, and may serve as a prognostic biomarker for predicting early metastasis. The inhibition of proliferation and invasion demonstrated by our MDA-MB-231 transfection experiments implies that NDRG1 is a tumor metastasis suppressor gene and may be a new candidate for gene therapy against human breast cancer.

Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation

MiR-96-5p Induced NDRG1 Deficiency Promotes Prostate Cancer Migration and Invasion Through Regulating the NF-κB Signaling Pathway.

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Abstract #1185: Loss of N-myc Downstream-Regulated Gene 1 (NDRG1) Increases Prostate Cancer Cell Invasion by Upregulating CCL5

Suppression of Microrna-454 Impedes the Proliferation and Invasion of Prostate Cancer Cells by Promoting N-myc Downstream-Regulated Gene 2 and Inhibiting WNT/β-catenin Signaling

NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation

Ndrg1 Regulates Filopodia-Induced Colorectal Cancer Invasiveness Via Modulating Cdc42 Activity

Ndrg3 Is An Androgen Regulated And Prostate Enriched Gene That Promotes In Vitro And In Vivo Prostate Cancer Cell Growth

Proteomics Analysis of the Interactome of N-myc Downstream Regulated Gene 1 and Its Interactions with the Androgen Response Program in Prostate Cancer Cells

miR-593-3p Promotes Proliferation and Invasion in Prostate Cancer Cells by Targeting ADIPOR1

The Metastatic Suppressor NDRG1 Inhibits EMT, Migration and Invasion Through Interaction and Promotion of Caveolin-1 Ubiquitylation in Human Colorectal Cancer Cells

Downregulation of NDR1 Contributes to Metastasis of Prostate Cancer Cells Via Activating Epithelial‐mesenchymal Transition

Identification of NDRG1-regulated genes associated with invasive potential in cervical and ovarian cancer cells.

MicroRNA181c Inhibits Prostate Cancer Cell Growth and Invasion by Targeting Multiple ERK Signaling Pathway Components

Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.

NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10

MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells

Tumor-suppressive Microrna-497 Targets IKKβ to Regulate NF-κB Signaling Pathway in Human Prostate Cancer Cells.

Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis

CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m6A-dependent manner